Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugs
Kazuaki Tanabe(Hiroshima University), Tetsuya Toge(Hiroshima University), Ryungsa Kim(Hiroshima Institute of Technology), Hideki Inoue(Kanagawa Institute of Technology), Yoko Uchida(Gunma University), Manabu Emi(Hiroshima University)
Cited by 37
Related Papers
Cancer immunoediting from immune surveillance to immune escape
|Immunology|2007|1k
The <i>C. elegans</i> p38 MAPK pathway regulates nuclear localization of the transcription factor SKN-1 in oxidative stress response
|Genes & Development|2005|451
Current status of the molecular mechanisms of anticancer drug-induced apoptosis
|Cancer Chemotherapy and Pharmacology|2002|255
The long-term survival of stage IV gastric cancer patients with conversion therapy
|Gastric Cancer|2017|168